Wavelength Intervention for Nearsighted Kids
WINK
Pilot Test of a Novel Wavelength-Based Method to Control Childhood Myopia
2 other identifiers
interventional
80
1 country
1
Brief Summary
The goal of this clinical trial is to learn if daily brief periods of specialized soft contact lens wear work to slow the progression of nearsightedness in children. Additionally, the study will learn about the compliance and safety of specialized soft contact lens wear in children. The main questions it aims to answer are: Does wearing specialized soft contact lenses daily slow myopia progression and axial elongation? What visual/ocular problems do participants have when wearing specialized soft contact lenses? Researchers will compare two soft contact lenses to see if specialized soft contact lens wear works to treat childhood myopia progression. Participants will
- 1.Wear either a single type of soft contact lens or two types of soft contact lenses at alternate times daily full time in both eyes for one year.
- 2.Visit the clinic at 2 weeks, 1 month, 3 months, 6 months, and 12 months for checkups and tests
- 3.Keep a diary of the lens-wearing times.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
April 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2027
October 8, 2025
October 1, 2025
2.2 years
September 13, 2024
October 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in cycloplegic spherical equivalent refractive error
Cycloplegic autorefraction measurements will be recorded using the WAM 5500 autorefractor in both eyes at baseline and follow-up visits. A set of 10 spherical equivalent measures will be obtained in each eye and later averaged to obtain the eye's final refractive error.
Baseline and 12 months
Change in axial length
Ocular component dimensions, including axial length, will be recorded using the Haag-Streit LenStar LS900 based on low-coherence interferometry. A set of five measurements in primary gaze in each eye will be averaged to obtain the final dimension of the ocular components.
Baseline and 12 months
Secondary Outcomes (3)
Change in choroidal thickness
Baseline and 12 months
Change in visual acuity
Baseline and 12 months
Change in accommodative response
Baseline and 12 months
Study Arms (2)
Group A
EXPERIMENTALChildren who are randomized to this group will wear one type of daily use, daily disposable, single-vision soft contact lens for at least four hours starting in the afternoon (after school) and another type of daily use, daily disposable, single-vision soft contact lens for the remainder of the time daily for one year.
Control group
SHAM COMPARATORChildren who are randomized to this group will wear daily use, daily disposable, single-vision soft contact lenses full time for one year. Contact lenses will be worn for a minimum of 10 hours per day.
Interventions
These are daily-wear, daily-replacement lenses. They are identical to specialized soft contact lens 2 in material, comfort, and lens geometry. They differ only in their spectral profile.
These are daily-wear, daily-replacement lenses. They are identical to specialized soft contact lens 1 in material, comfort, and lens geometry. They differ only in their spectral profile.
Eligibility Criteria
You may qualify if:
- Spherical component of refractive error in primary meridian between -0.75 and -5.00 D
- Less than 1.00 D of astigmatism or anisometropia
- History of soft contact lens wear for at least a week
- Best-corrected visual acuity of 20/25 (+0.10 logMAR) or better in each eye
- Willingness to wear the lenses for a minimum of 10 hours/day, at least six days a week for the duration of the study
You may not qualify if:
- Subjects receiving myopia control treatments within the past six months
- History of premature (less than 3.3 lb) or preterm birth (earlier than 30 weeks)
- Current history of using systemic or ocular medications (including artificial tears) that may affect contact lens wear, tear film health, refractive state, pupillary response or accommodative function
- History of ocular or systemic diseases, including those that may affect refractive development
- Known allergy to fluorescein, benoxinate, proparacaine, or tropicamide
- Contact lens contraindications (e.g., giant papillary keratoconjunctivitis)
- Corneal disorders (e.g., hypoesthesia, keratoconus)
- Strabismus at distance or near with distance glasses or contact lenses
- Subjects exhibiting poor personal hygiene that may affect the compliance of contact lens wear.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Alabama at Birminghamlead
- National Eye Institute (NEI)collaborator
Study Sites (1)
University of Alabama at Birmingham School of Optometry
Birmingham, Alabama, 35233, United States
Related Publications (3)
Khanal S, Norton TT, Gawne TJ. Amber light treatment produces hyperopia in tree shrews. Ophthalmic Physiol Opt. 2021 Sep;41(5):1076-1086. doi: 10.1111/opo.12853. Epub 2021 Aug 11.
PMID: 34382245BACKGROUNDGawne TJ, Grytz R, Norton TT. How chromatic cues can guide human eye growth to achieve good focus. J Vis. 2021 May 3;21(5):11. doi: 10.1167/jov.21.5.11.
PMID: 33984119BACKGROUNDGawne TJ, She Z, Khanal S. Human trichromacy and refractive development. Vision Res. 2025 Sep;234:108632. doi: 10.1016/j.visres.2025.108632. Epub 2025 Jun 9.
PMID: 40494187BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Safal Khanal, OD, PhD
Unversity of Alabama at Birmingham
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 13, 2024
First Posted
September 19, 2024
Study Start
April 10, 2025
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
July 31, 2027
Last Updated
October 8, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis
- Access Criteria
- Access to trial IPD can be requested by qualified researchers engaging in independent scientific research and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA). For more information or to submit a request, please contact skhanal@uab.edu.
Data obtained through this study may be provided to qualified researchers with academic interest in myopia. Data will be coded, with no PHI included. Approval of the request and execution of all applicable agreements are prerequisites to the sharing of data with the requesting party.